The Use of 13C-Urea Breath Test for Non-Invasive Diagnosis of Helicobacter pylori Infection in Comparison to Endoscopy and Stool Antigen Test

Hamed Alzoubi; Asma'a Al-Mnayyis; Ibrahim Al Rfoa; Amin Aqel; Mohammad Abu-Lubad; Omar Hamdan; Kareem Jaber

doi:10.3390/diagnostics10070448

The Use of ¹³C-Urea Breath Test for Non-Invasive Diagnosis of Helicobacter pylori Infection in Comparison to Endoscopy and Stool Antigen Test

Diagnostics (Basel). 2020 Jul 3;10(7):448. doi: 10.3390/diagnostics10070448.

Authors

Hamed Alzoubi¹, Asma'a Al-Mnayyis², Ibrahim Al Rfoa³, Amin Aqel¹, Mohammad Abu-Lubad¹, Omar Hamdan⁴, Kareem Jaber⁵

Affiliations

¹ Department of Microbiology and Immunology, Faculty of Medicine, Mu'tah University, Alkarak 61710, Jordan.
² Department of Clinical Sciences, College of Medicine, Yarmouk University, Shafiq Irshidat St, Irbid 21163, Jordan.
³ Gastroenterology Unit, Alkarak Teaching Hospital, Alkarak 61710, Jordan.
⁴ Departmrnt of Pathology, Faculty of Medicine, Mu'tah University, Alkarak 61710, Jordan.
⁵ Deapartment of Pathology, Microbiology and Forensic Medicine, Jordan University, Amman 11924, Jordan.

Abstract

Helicobacter pylori (H. pylori) can cause gastritis, peptic ulcer diseases and gastric carcinoma. Endoscopy as the gold standard method of diagnosis is an invasive procedure that might not be suitable in all scenarios. Therefore, this first study in Jordan aimed to assess the non-invasive ¹³C urea breath test (UBT) and stool antigen test for diagnosis of H. pylori infection and the successfulness of eradication therapy as alternatives for endoscopy. Hence, a total of 30 patients attending the endoscopy units at Alkarak teaching hospital were asked to complete a questionnaire with demographic and clinical data. They were then tested for H. pylori using ¹³C UBT and H. pylori stool antigen before having endoscopy. Another 30 patients who were positive for H. pylori by endoscopy were tested using both tests 6 weeks post eradication therapy. Results showed that the rate of H. pylori detection using endoscopy was 56.7% (17/30). Heartburns (82.3%, p value = 0.019), epigastric pain (88.2%, p value = 0.007) and vomiting (70.5%, p value = 0.02) were the most significant symptoms. Family history of peptic ulcer diseases was significantly associated with an increased risk for having a H. pylori positive result (p value = 0.02). Compared to endoscopy, the sensitivity of ¹³C UBT for the diagnosis of H. pylori was 94.1% (16/17), while it was 76.5% (13/17) for the stool antigen test. The specificity of both tests was equal (76.9%). However, the positive predictive and negative predictive values (84.2% and 90.9%) for ¹³C UBT were higher than those (81.3% and 71.4%) for the stool antigen test. The accuracy of ¹³C UBT was 86.7% compared to 76.7% for the stool antigen test. There was an 87% agreement (20 patients out of 23) between both tests when used to assess success of the eradication therapy. In conclusion, the ¹³C UBT was found to be more sensitive and accurate than the stool antigen test when used for diagnosis; furthermore, it has a comparable outcome to the stool antigen test in assessing the successfulness of the eradication treatment.

Keywords: 13C urea breath test; Helicobacter pylori; endoscopy; sensitivity; stool antigen test.